-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IOKQNeMy2eKUybbL8yhU6i9SUk5MNljoJFh1YDUETBF+hMfCcX07OHK9L7fcBDv6 Ol34VC/odaWSEoWXuEu2mA== 0001144204-10-059227.txt : 20101112 0001144204-10-059227.hdr.sgml : 20101111 20101112062601 ACCESSION NUMBER: 0001144204-10-059227 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101111 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20101112 DATE AS OF CHANGE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kun Run Biotechnology, Inc. CENTRAL INDEX KEY: 0001393526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980517550 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53621 FILM NUMBER: 101182421 BUSINESS ADDRESS: STREET 1: 243 CRANFIELD GREEN SE CITY: CALGARY STATE: A0 ZIP: T3M 1C4 BUSINESS PHONE: 403-370-1176 MAIL ADDRESS: STREET 1: 243 CRANFIELD GREEN SE CITY: CALGARY STATE: A0 ZIP: T3M 1C4 FORMER COMPANY: FORMER CONFORMED NAME: Aspen Racing Stables. Inc. DATE OF NAME CHANGE: 20080307 FORMER COMPANY: FORMER CONFORMED NAME: Aspen Racing Stables DATE OF NAME CHANGE: 20070316 8-K 1 v201977_8k.htm Unassociated Document
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
        
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): November 11, 2010
 
         
 
Kun Run Biotechnology, Inc.
(Exact name of registrant as specified in Charter)
 
Nevada
 
333-141384
 
98-0517550
(State or other jurisdiction of
incorporation or organization)
 
(Commission File No.)
 
(IRS Employee
Identification No.)
 
Free Trade Zone
168 Nanhai Avenue, Haikou City
Hainan Province, China 570216
(Address of Principal Executive Offices)
 
86-898-6680-2207
(Issuer Telephone number)
 
Aspen Racing Stables, Inc.
(Former name and former address, if applicable)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 
Item 7.1 Regulation FD 
 
 In July 2010, Kun Run Biotechnology, Inc. ( the “Company”) received a notice from the Hainan Food and Drug Administration that the agency would investigate certain products of the Company due to production procedure concerns and at the same time the GMP license of the Company would be suspended until the investigation is concluded.  As result of the notice, the Company ceased its production of all products.  The Company at the time believed that the investigation would end shortly and would not have an adverse impact on the results of its operations due to the then existing inventories.  However, as of the date of this report, the agency has not concluded its investigation.  The Company believes that due to the prolonged investigation, it is unlikely that its production will resume any time soon and its results of operations will be adversely impacted.


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
KUN RUN BIOTECHNOLOGY, INC.
(Registrant)
 
       
Dated: November 11, 2010
By:
/s/ Xiaoqun Ye 
 
   
Name: Xiaoqun Ye
 
   
Title: Chief Executive Officer 
 
 
 
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----